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| INTRODUC TI ON
Preterm birth has been associated with a number of long-term sequelae, including increased risks of cardiovascular disease and osteoporosis. 1, 2 The link between prematurity and cardiovascular disease might be explained by altered fat tissue development, as preterm-born children were found to have an increased fat mass (FM) at term equivalent age compared to term-born peers. 3 This pattern was reported, although not unequivocally, to persist beyond infancy. [4] [5] [6] [7] [8] Likewise, some studies showed a lower bone mass or bone mineral density (BMD) after preterm birth around term age, but also at school age, which could not be confirmed by others. 2 A multifactorial mechanism, where endocrine systems play an important role, might underlie these differences.
Insulin-like growth factor 1 (IGF-1) is a key regulator of growth and affects metabolic processes such as glucose and lipid metabolism, and thereby body composition. In addition, IGF-1 regulates longitudinal bone growth through stimulation of chondrocytes in the growth plate and increases BMD. 9 Leptin is a regulator of food intake and energy expenditure through its effects on the central nervous system. [10] [11] [12] The association between leptin and FM has been extensively described, although predominantly in adult, obese populations. In term-born children at school age, leptin has also been positively associated with FM index (ie FM adjusted for height 2 ). 13, 14 We showed that this association was also present in preterm-born children at term age and 6-month corrected age (CA, ie calculated from term age). 15 More recently, leptin has been suggested to be involved in bone metabolism, although its exact role has yet to be determined. A commonly adopted hypothesis encompasses a combination of two pathways: a central pathway via hypothalamic activation of the sympathetic nervous system that inhibits bone formation and a peripheral pathway through leptin receptors on osteoblastic cells that increases bone formation. 16, 17 Data on this association in children are scarce, and current literature is inconclusive, with studies reporting positive, negative or no associations. 14, 18 In children born preterm (between 32 and 37 weeks of gestation), no relation was found between cord blood leptin and lumbar spine BMD at the age of 2 years. 19 To our knowledge, no studies have investigated associations between leptin and bone metabolism in children born before 32 weeks of gestation.
Considering the positive association between leptin and FM found during infancy in our cohort, the aim of this study was to investigate whether this association persists and to explore the association between leptin and body composition, including bone parameters, from infancy to age 8 years. In addition, we studied whether IGF-1 was associated with leptin, body composition and bone parameters.
| SUBJEC TS AND ME THODS
The study protocol was approved by the Ethics Committee of the VU University Medical Center Amsterdam, the Netherlands, and all parents of participants gave written informed consent.
| Subjects
All subjects included in this study originally participated in a nutritional RCT (Study Towards the Effects of Postdischarge nutrition, STEP), which has been described in detail before. 20 For this study, infants were randomized at term age to receive either an isocaloric protein-and mineral-enriched postdischarge formula (PDF) or standard term formula (TF) and were fed this diet until 6-month CA. A control group of children fed human milk (HM) was also included. Subjects visited the outpatient clinic at term age, at 3-and 6-month CA, and, for the follow-up study (STEP-2), at chronological age 8 years. Of the original cohort of 152 children, 21 were excluded or lost to follow-up at 8 years, and 52 refused to participate or could not be traced, resulting in 79 children who were included in the follow-up study. Exclusion criteria were severe physical impairment or conditions known to affect growth or body composition. Participants and nonparticipants of the follow-up were comparable in terms of perinatal and demographic characteristics as described previously. 21 The cohort retrieval is described in detail elsewhere. 21 
| Measurements
Weight and length/height were measured during each study visit using standard methods, 20, 21 and absolute values were converted to standard deviation scores (SDS) with the use of appropriate reference data. 22, 23 Children with a weight and/or length at birth ≤−2SDS
were classified as small-for-gestational-age (SGA). 
| Laboratory parameters

| Statistical analyses
Normally distributed data were presented as means ± SDs and skewed data as medians [interquartile ranges, IQRs]. Skewed outcome variables were natural log-transformed before use in linear regression analyses.
Cross-sectional associations between leptin or IGF-1, and FM, LM, BMC, and BMD were analysed using linear regression analyses, and longitudinal associations were analysed using linear mixed models with fixed effects and a diagonal repeated covariance type.
All analyses were adjusted for sex, as this is a known confounder in analyses with leptin and body composition. Linear regression analyses with BMC as outcome variable were additionally adjusted for simultaneously measured BA and length/height. 26 Outcomes of linear regression analyses are reported as β (95% confidence interval [CI]), P value, and, if appropriate, adjusted R 2 (R 2 adj , ie the proportion of the variance in the dependent variable that is predictable from the independent variable(s)). Because of strong collinearity between FM and leptin, the analyses with either of those parameters as covariable were not adjusted for the other.
All analyses were adjusted for type of feeding (ie PDF, TF, and HM) in addition to sex, as this was a post hoc analysis of a nutritional RCT. Previous analyses in this cohort showed that body composition at 6-month CA differed between the feeding groups. 20 Moreover, nutrition (in particular protein) is a known regulator of IGF-1 and possibly also of leptin. BA, bone area; BMC, bone mineral content; BMD, bone mineral density; CA, corrected age; FM, fat mass; HM, human milk; IGF-1, insulin-like growth factor 1; LM, lean mass; PDF, postdischarge formula; SDS, standard deviation score; SGA, small-for-gestational-age; TF, term formula. Data are presented as mean ± SD, n (%) or median [IQR] . *Male vs female P = .015, P = .046, P = .001 and P = .006, for increasing ages, respectively. **IGF-1 compared between the feeding groups of the original RCT: PDF vs HM 3-mo CA P = .002, 6-mo CA P = .016. ***Male vs female P < .05, data not shown separately.
TA B L E 1 Characteristics of the study population
All statistical analyses were performed with IBM spss Statistics version 22. Statistical significance was defined as a P value of < .05.
| RE SULTS
A total of 79 children were included in the follow-up study at a mean age of 7.9 (range 7.1-8.6) years. Leptin and IGF-1 concentrations in combination with DXA-parameters were available for 70, 68 and 55 children at term age, 6-month CA and 8 years, respectively. Leptin at 3-month CA was available for 73 children.
| Leptin and IGF-1 in infancy and at 8 years
Girls had significantly higher leptin, but similar IGF-1 levels compared with boys at all 4 time points (Table 1) . Leptin was similar between F I G U R E 1 Association between leptin/IGF-1 measured at 6-mo corrected age (CA) and 8 y. Results of regression analyses were adjusted for sex and type of feeding from term age to 6-mo CA. the feeding groups at all time points (all P (Figure 1) . A positive association was found between IGF-1 and leptin for each time point separately, with the exception of 6-month CA (data not shown).
| Leptin-body composition and bone parameters
At term age, 6-month CA and 8 years, leptin was associated with FM (P < .001, R 2 adj 30%-66%). Leptin at 3-month CA was associated with FM at 6-month CA (P < .001, R 2 adj 39%). At 8 years, leptin was associated with LM, P = .002, R 2 adj 17% (Table 2) . In longitudinal analyses, leptin was associated with FM (β 0.16, 95% CI 0.13; 0.19, P < .001, Figure 2A ) and LM (β 0.10, 95% CI 0.01; 0.19, P = .029) over time.
At term age and 6-month CA, leptin was positively associated with BMC and BMD ( Table 2 ). Adjusting the associations between leptin and BMC for BA and length/height, in addition to sex and type of feeding, resulted in weaker, but still significant associations, and increased the explained variation in BMC (ie an increase in R 2 adj ): at term age from 30% to 81% and at 6-month CA from 19% to 84%.
Leptin measured at 3-month CA was associated with BMC and BMD at 6-month CA (R 2 adj 84% and 27%, respectively, when adjusted for sex, type of feeding, BA and length). In crude and adjusted analyses, leptin, regardless of time point, was not associated with BMC or BMD at 8 years (Table 2) .
In longitudinal analyses, leptin was associated with BMC (β 7.13, 95% CI 5.07; 9.20, P < .001; Figure 2A ) and BMD (β 0.01, 95% CI 0.01; 0.01, P < .001) over time.
| IGF-1-body composition and bone parameters
At term age, 6-month CA and 8 years, IGF-1 was associated with FM (R 2 adj 6%-13%) ( Table 3) . IGF-1 at 3-month CA was positively associated with FM at 6-month CA (R 2 adj 6%). In longitudinal analyses, IGF-1 was associated with FM (β 0.10, 95% CI 0.08; 0.13, P < .001, Figure 2B ) and LM (β 0.21, 95% CI 0.15; 0.26, P < .001) over time. At 8 years, IGF-1 was associated with LM (R 2 adj 19%; Table 3 ).
F I G U R E 2 Leptin (A) and IGF-1 (B) with fat mass (FM) and bone mineral content (BMC) at term age, 6-mo corrected age (CA) and 8 y. Longitudinal analysis of these data showed significant associations over time (P < .001) At term age, 6-month CA and 8 years, IGF-1 was positively associated with both simultaneously measured BMC (data not shown) and BMD (R 2 adj 8%-17%; Table 3 ). After adjusting the BMC analyses for BA and length/height, in addition to sex and type of feeding, the associations between IGF-1 and BMC were no longer significant (Table 3 ). However, there was an increase in the explained variation in BMC (ie an increase in R 2 adj ): at term age from 14% to 79%, at 6-month CA from 10% to 82% and at 8 years from 17% to 74%.
In longitudinal analyses, IGF-1 was associated with BMC (β 4.23, 95% CI 2.78; 5.68, P < .001; Figure 2B ) and BMD (β 0.01, 95% CI 0.01; 0.01, P < .001) over time.
| Body composition and bone
Body composition and bone parameters were associated with one another at most of the time points (Table 4) .
This was confirmed in longitudinal analyses in which FM and LM were strongly associated with BMC and BMD over time (data not shown).
Adjusting the analyses with BMC for BA and length/height, in addition to sex and type of feeding, resulted in weaker associations between FM or LM and BMC, but an increase in the explained variation in BMC (ie an increase in R 2 adj ): at term age from 60% to 83%/54% to 80%, at 6-month CA from 64% to 84%/27% to 82% and at 8 years from 20% to 79%/62% to 85%, for FM and LM, respectively.
| D ISCUSS I ON
In children born preterm, we showed that leptin and IGF-1 were associated with FM during infancy and childhood, and that the association between leptin and bone in infancy was no longer present in childhood. Bone area and height were found to be more important for bone mineralization than were the investigated endocrine parameters. There appeared to be no predictive value of endocrine parameters measured in infancy on body composition and bone at age 8 years.
Studies on leptin in the neonatal period have described relations with several perinatal characteristics, including positive associations with foetal growth, gestational age and birth weight. 27, 28 Likewise, the effects of IGF-1 during early life of preterm-born TA B L E 3 Associations of IGF-1 with body composition and bone parameters from infancy to 8 years infants have been extensively described. 29, 30 Decreased levels of IGF-1 in early postnatal life have been associated with neonatal morbidities such as bronchopulmonary dysplasia and retinopathy of prematurity, as well as with impaired growth, adverse neurodevelopment and unfavourable body composition. 29, 30 We previously showed that leptin was associated with FM and weight gain between term age and 6-month CA, 15 and that IGF-1, together with insulin, was suggested to be involved in the regulation of growth during infancy. We demonstrated a similar relation between leptin, IGF-1 and FM, although the latter was not adjusted for height.
In contrast to our results, a study in 7-to 8-year-old term-born children showed positive associations between IGF-1 and total body BMC, and between leptin and lumbar spine BMD. 14 However, consistent with our results, the same study found no independent effect of leptin on total body BMC and concluded that hormones only explained a relatively small proportion of variation in body composition or bone parameters. In addition, they found that LM and FM largely explained variation in BMC, 14 unlike our results that suggest a substantial contribution of BA and height. The latter finding may be supported by studies suggesting that increased leptin concentrations contribute to growth velocity and bone maturation. 31, 32 Then again, others showed that neither leptin and IGF-1, nor FM were associated with BMC adjusted for height and BA. 33 Assessing the actual effect of each of the discussed parameters separately, in particular since leptin and FM are strongly related, is difficult and this makes it hard to draw firm conclusions. It has also been suggested that the effect of leptin on bone in early and later life involves other components of bone metabolism, 17 and this might be reflected in the differences we found between infancy and childhood. Furthermore, considering the theory of a central inhibitory and peripheral stimulating effect of leptin on bone, we hypothesize that in preterm-born infants, it may take some time before a balance between these two pathways is reached. In addition, an inverse association between IGF-1 in infancy and at 17 years has been described in healthy term-born children, 34 which was exactly opposite to the positive association that we found. We might speculate that we found this association as part of an ongoing change in the IGF-1 axis towards an eventually inverse association. In summary, it is probably fair to assume that a complicated interaction of multiple (counteractive) pathways, most likely also changing over time, is involved in the regulation of body composition and bone mineralization of preterm-born infants.
TA B L E 4 Association between body composition and bone parameters from infancy to 8 years 
| Strengths and limitations
The main strength of this study was the follow-up of preterm-born children from birth until age 8 years with repeated measurements of endocrine parameters and body composition. This study also has several limitations. First, the analyses performed are post hoc analyses of a nutritional RCT that did not include a term-born control group. A direct comparison with healthy peers can, therefore, not be made and only associations, not causal pathways, can be investigated. Second, attrition at follow-up, which is practically inevitable in long-term follow-up studies, 35 limited our sample size. In addition, refusal by participants or failure of obtaining blood further reduced our sample size, at least regarding the analyses with blood parameters.
As a consequence, subgroups were too small to perform analyses for boys and girls separately, in spite of differences between sexes in hormone concentrations and body composition. Instead, we adjusted our analyses for sex. Third, blood was obtained from term age, while the period between birth and term age is probably more important for the future settings of hormonal systems. 36 Fourth, even though we found strong significant associations, as a consequence of the design of our study we could not prove causality. Furthermore, with regard to clinical relevance, it is important to take regression coefficients (beta's), as a proxy for effect sizes, into account as well.
Additionally reporting the adjusted R 2 gives insight in the proportion of the variance in the outcome variables that is explained by the independent variables and may facilitate interpretation of the associations that we found. From that it could be concluded that sex, BA and height are important contributors to variation in bone mineralization, specifically at 8 years. What the exact role of leptin is in bone metabolism of preterm-born children remains uncertain. Follow-up beyond childhood is necessary to investigate the long-term effects of leptin and IGF-1 on body composition and bone parameters in children born preterm.
| CON CLUS ION
Leptin and IGF-1 were associated with body composition and bone parameters, although the latter only in infancy and not in childhood in our cohort of preterm-born children. This may suggest that during childhood, other characteristics (such as sex, bone area (BA) and height) become more important for bone mineralization.
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